Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses.
about
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Gastrointestinal cytomegalovirus disease in a patient with pemphigus vulgaris treated with corticosteroid and mycophenolate mofetilIs There a Role for Opportunistic Infection Prophylaxis in Pemphigus? An Expert Survey.Screening for infections prior to initiating immunosuppressive treatment for patients with autoimmune blistering diseases.Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines
P2860
Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Evidence-based guidelines for ...... autoimmune bullous dermatoses.
@en
type
label
Evidence-based guidelines for ...... autoimmune bullous dermatoses.
@en
prefLabel
Evidence-based guidelines for ...... autoimmune bullous dermatoses.
@en
P2093
P2860
P356
P1476
Evidence-based guidelines for ...... autoimmune bullous dermatoses.
@en
P2093
D A Wetter
J S Lehman
J W Wilson
P2860
P304
P356
10.1111/BJD.13355
P407
P577
2014-11-19T00:00:00Z